Although survival after acute coronary syndrome (ACS) has improved, ACS is still associated with significant
morbidity and mortality. Secondary prevention is crucial to minimising the risk of future cardiovascular events
after ACS. Secondary prevention measures extend beyond pharmacological therapy alone and patients may benefit
from the input of a multidisciplinary team. Support of a GP is crucial to achieving long-term success in
secondary prevention therapy.
Modern Medicine – January 2018